Intuitive Announces Preliminary Fourth Quarter and Full Year 2020 Results

NEXT STORY
Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study
PREV STORY
Arcutis Initiates Pivotal Phase 3 Clinical Trials Evaluating Topical Roflumilast Cream (ARQ-151) as a Potential Treatment for Atopic Dermatitis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CHF Solutions Announces First Patient Enrolled in the ULTRA-Peds Registry

author_avatar
NASDAQ Market News

Global Infectious Diseases Diagnostics Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

author_avatar
NASDAQ Market News

Research From Exergen Corporation Shows Morning-Only Temperature Readings May Miss up to Half of All Fevers

author_avatar
NASDAQ Market News